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Abstract
Backgound: The concept of Human Rights has become the modern civilising standard to which
all should aspire and indeed attain.
Discussion: In an era characterised by widening disparities in health and human rights across the
world and spectacular advances in biotechnology it is necessary to reflect on the extent to which
human rights considerations are selectively applied for the benefit of the most privileged people.
Attention is drawn particularly to sub-Saharan Africa as a marginalised region at risk of further
marginalisation if the power associated with the new biotechnology is not used more wisely than
power has been used in the past. To rectify such deficiencies it is proposed that the moral agenda
should be broadened and at the very least the concept of rights should be more closely integrated
with duties
Summary: New forms of power being unleashed by biotechnology will have to be harnessed and
used with greater wisdom than power has been used in the past. Widening disparities in the world
are unlikely to be diminished merely by appealing to human rights. We recommend that a deeper
understanding is required of the underlying causes of such disparities and that the moral discourse
should be extended beyond human rights language.
Background
In an era characterised by both major advances in biotech-
nology and a high profile for the idea of human rights, it
is necessary to ask whether, when we speak about human
rights, we are concerned about the rights of the 1 billion
people who live so well and who have so much to look
forward to from the benefits of further scientific progress
or the rights of the 4 billion people who live under miser-
able conditions?
It is necessary to ask this question for many reasons. First-
ly, because the disparities between the lives of people who
fall into these two categories have been constantly widen-
ing over the past 30 years and there is little evidence that
this pattern will be reversed. Secondly, because the abuse
of power has been a significant force in contributing to
wide disparities in human lives and to gross violations of
human rights. Thirdly, because there is little to suggest
that the new power that will be available in the biotech-
nology era will be used more wisely than other forms of
power have been used in the past. Global economic proc-
esses have extracted material and human resources from
many poor countries, eroded the value of their currencies
and placed their economies at the mercy of such unac-
countable organisations as the International Monetary
Fund and the World Bank. [2–4] Massive deprivation of
citizens of poor nations has also been promoted through
the sale of arms to corrupt leaders, enabling them to accu-
mulate vast wealth and to wage wars of ethnic conflict,
with devastating social effects. [5]
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What will happen in the era of biotechnology to improve
the lives of the poor? Will advances in plant, animal or hu-
man genetic engineering enable major pharmaceutical
and agrochemical companies to produce cheaper drugs
and food and will the sentiments expressed in the Univer-
sal Declaration of the Human Genome be respected – as
optimistically suggested by some? [6] Alternatively will
the insistence on intellectual property rights and reduc-
tion in the biological diversity of agricultural products dis-
rupt the economies of poor nations and ensure that food
prices continue to rise and malnutrition aggravated? Is it
possible that genetic data from some groups of people will
be exploited for economic benefit, or even more horrify-
ingly, to develop weapons for genocidal purposes? If
drugs for malaria, tuberculosis, many tropical diseases
and HIV/AIDS have not been made available to billions in
poor countries is it likely that the poor will benefit from
advances in biotechnology?
Understanding that science is not value free provides
some insights. "Scientific knowledge emerges from a proc-
ess that is intensely human, a process indelibly shaped by
human virtues, values and limitations and by social con-
texts... Science is a social enterprise...and takes place with-
in a broad social and historical context, which gives
substance, direction, and ultimately meaning to the work
of individual scientists... Individual knowledge only be-
comes general knowledge after discussion, collaboration,
peer review, judgement and incorporation into already ac-
cepted knowledge – an ongoing process of review and re-
vision that minimises individual subjectivity." [7]
Several facts illustrate the assertion that science is not val-
ue free. Sixty six percent of the USA Government's expend-
iture on research and development is on military research
[5]. Ninety percent of global expenditure on medical re-
search is on diseases causing 10% of global burden of dis-
ease, [8] and of 1233 new drugs developed between
1975–1997 only 13 were for the tropical diseases. These
observations suggest that the questions pursued by scien-
tists are determined less by the need for knowledge and
how to apply knowledge that by the economic forces that
drive and support the research endeavour. Indeed there is
a need to understand the global economic context in
which market forces rather than human needs drive the
research endeavour. The emphasis on military research
and the neglect of diseases that afflict billions of people
living in abject misery reflects a value system that margin-
alises and devalues the lives of more than half the world's
population.
Discussion
While the Universal Declaration on the Human Genome,
the first universal instrument in the field of biology, sets
out to safeguard human rights, fundamental freedoms
and the freedom of research, [9] it is clear that there are
many obstacles to achieving the high ideals expressed in
this document. For example despite the statement in Arti-
cle 4 that "the human genome in its natural state shall not
give rise to financial gains," and in Article 6 that "no one
shall be subjected to discrimination based on genetic
characteristics," "there is already evidence to suggest that
these requirements will be ignored." Considerations of
"who will offer what to whom and at whose expense in
health care in the USA" have been explored in detail and
concern expressed that genetic information will be used
adversely to influence access to health care in a nation
with "a long and disturbing history of drawing sharp dis-
tinctions among (its) citizens on the basis of race and eth-
nicity" as well as "a long tradition of belief in biological
determinism." [10]
The implications of genetic testing for medical practice
and for the rights of privacy of individuals are many, var-
ied and problematic. Shifting the frontier of medicine
from curing diseases and caring for individual persons, to-
wards the public health goals of preventing suffering in fu-
ture generations, and even to the possibility of enhancing
physical and mental capacities, poses major challenges to
the concept of human rights. The ability to improve pub-
lic health through mandatory vaccinations, at the cost of
potential suffering of some adverse reactions to vaccines is
widely accepted. While such acceptance of social benefit
over individual rights does not apply now to predictive
and carrier testing for genetic abnormalities or to correct-
ing genetic abnormalities – and indeed the analogy drawn
here is not exact – in due course public health considera-
tions may also achieve over-riding importance. A new bal-
ance may need to be established regarding the rights of
individuals and the rights of groups in order to improve
public health, although great caution will be needed to
avoid undue coercion.
Also problematic is the generation of massive amounts of
genomics data that drives megamergers by companies
seeking patents. The USA patent and trademark office has
received thousands of requests for patents on nucleic acid
sequences, and major biotechnology, chemical, pharma-
ceutical and agribusiness companies are investing in mo-
lecular technologies. Techniques paving the way to
controlling farming and world food production by giant
agrochemical companies may threaten subsistence farm-
ers in poor countries. Reduction of the genetic diversity of
agricultural products or excessive protection of intellectu-
al property rights, locking farmers into corporate control
of production, could have profoundly adverse effects on
the economies of developing countries and the lives of
their citizens. [11] Alternatively, more optimistic attitudes
[6] need to be vigorously promoted in order to alter exist-
ing patterns of behaviour.BMC International Health and Human Rights 2002, 2 http://www.biomedcentral.com/1472-698X/2/3
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At least three key risks are associated with the new life sci-
ence industry: (i) the excessively high valuation of some
life science conglomerates could substantially influence
the international stock market, (ii) genetically engineered
products may be widely used before they have been rigor-
ously tested, and (iii) developments in biotechnology are
outstripping public understanding – and hence eroding
both the trust and confidence of the public [11,12].
In 1991 when the Human Genome Diversity Project was
proposed, critics of the project argued that minority pop-
ulations struggling for survival needed economic support
and not the preservation of their genes or "immortalisa-
tion" in laboratories. Plans to put the health records of
every Icelandic citizen into a huge data base with private
company rights to analyse and market the data, and to ex-
ploit the genetic composition of Icelanders are other ex-
amples of practices that cause great concern [13].
How will individual human rights be protected under
these circumstances? More declarations will not be suffi-
cient. Against the background of power abuse in this cen-
tury, it can be justifiably concluded that human rights
declarations, despite their best intentions, have not
achieved as much as desired to guarantee widespread ac-
cess to even the most basic requirements for a decent hu-
man existence. It therefore becomes necessary to question
whether in the era of biotechnology the language of rights
alone can enable achievement of the respect we desire for
all individuals, or whether the moral goods to which we
aspire require a richer moral language and greater empha-
sis on social justice?
In defence of the Human Rights approach, as the single
most powerful means of promoting human well-being, it
can be argued that failure to achieve human rights more
widely is not the result of an inadequate concept of hu-
man rights, but rather that the full potential of the human
rights approach has not been achieved because of simplis-
tic or insincere use of the term, and a lack of commitment
by powerful nations to what a more wholesome concept
of human rights means and implies for them as well as for
others. Civil and political rights are required components
of political citizenship of any nation. However, recogni-
tion of political citizenship is not sufficient for human
flourishing. Recognition of social, economic and cultural
rights are also necessary. The claimed universality and in-
divisibility of human rights reflects the need for both sets
of rights in order to achieve respect for the dignity of indi-
viduals. Rights and responsibilities are inextricably related
and must be reintegrated to enhance the power of human
rights language, as proposed by Chapman [14] and in the
Universal Declaration of Human Duties that has recently
offered as a supplement to the UDHR [15].
As powerful as exhortation and pleas for human rights
may be, the power of wealthy countries in setting a moral
example is potentially more influential. This point is illus-
trated by fact that a powerful nation that has failed to rat-
ify social and economic rights and that propagates the
concept solely for civil and political rights is, in the wake
of the September 11 attack on the World Trade Center and
the Pentagon, legislating to curtail even these rights. The
implications of such action for global propagation of the
human rights concept are of great concern [16]. The US
backed complaint by pharmaceutical companies against
South Africa's intention to import generic drugs to deal
with the human tragedy of HIV/AIDS, while taking such
action themselves to over-ride Trade Related Intellectual
Property Rights (TRIPS) to import drugs for a potential
public health anthrax threat makes a mockery of claims of
concern for universal rights and security [17]. The short-
comings of a narrow approach to human solidarity and
morality reflect the need for a more coherent approach to
moral behaviour with full consideration of the co-relative
duties that form part of the conceptual logic of rights lan-
guage and its moral grip [18–20].
Some considerations from Africa
The African continent has long been central to the aspira-
tions of the West. Initially presenting great challenges to
circumnavigation, it became a continent inviting explora-
tion resulting in a clash of civilisations, enslavement of its
people, colonisation and extraction of its resources. Since
the release of Africa to independence, the collusion of
powerful nations with despotic leaders and their co-op-
tion into neo-liberal economic policies, enslavement has
continued covertly. The tragedy of the continent is now
aggravated by its elimination from the foreign policy
agendas of powerful countries because of crises conven-
iently perceived to be of its own making [19]. Endeavours
to restore Africa to a position of strategic and moral im-
portance to the US are to be admired [21].
The problems of Africa are so enormous that the debate
on genetic engineering has had a minimal profile on the
continent. The use of biotechnology to mass produce
drugs such as insulin and vaccines, to develop more resil-
ient crops, to increase the efficiency of food production, or
in other ways that improve the lives of individuals, would
be uniformly welcomed, especially if such techniques of-
fer to reduce the cost and increase access for all to drugs,
vaccines and food. However, as in the past it is likely that
such developments will be denied to the poor, or may
only trickle down sporadically. Genetically engineered
production of insulin, for example, creates a product
more expensive than animal insulin and the poor now
have less access to insulin than in the past. Pleas for dona-
tions of insulin (less than 0.5% of global use) to type 1 di-
abetics in the developing world have not been heededBMC International Health and Human Rights 2002, 2 http://www.biomedcentral.com/1472-698X/2/3
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'[22]. In addition techniques that are now paving the way
to controlling farming and world food production by gi-
ant agrochemical companies are seen as threats to farm-
ers.
Attempts to patent products developed with information
derived from the practices of indigenous healers, and ea-
gerness to patent components of the human genome for
exclusive economic gain are viewed as new forms of ex-
ploitation that exclude considerations of the humanity of
those living in economic misery [23]. The way in which
power has been used in the past thus gives rise to valid
concerns that the power of genetic engineering may also
be used for the exclusive good of some, or to harm others.
Contributions from biotechnology to the development of
biological weapons are adding new dimensions of mili-
tary horror to future conflicts. [24] During the Truth and
Reconciliation Commission's investigations into biologi-
cal warfare in South Africa it was revealed that there had
been programs designed to investigate methods of inter-
fering with the ability of Africans to reproduce. [25]. This
gives some credibility to more widespread fear among the
marginalised and oppressed of the world that knowledge
gained from the Human Genome Project and the Human
Genome Diversity Project may be used for genocidal pur-
poses
Secular western attitudes to the concept of the self as high-
ly individualistic, and unconnected to the wider commu-
nity or spiritual world further undermines the confidence
of Africans who view people as both uniquely individual
and as spiritually connected by relationships to others in
the present, past and future.
Summary
Clearly the new forms of power being unleashed by bio-
technology will have to be harnessed and used with great-
er wisdom than power has been used in the past. Like
nuclear power, biotechnology has the capacity for great
harm and this must be avoided. The resources and energy
being devoted to ethical aspects of biotechnology reflect
our awareness and concern for potential abuse. [6] Can
we be successful? I should like to be cautiously optimistic
that we can – but only if the nascent intellectual forces
moving the world towards new ways of thinking and act-
ing [26] can be transformed into more widespread atti-
tudes among citizens, governments and multinational
organisations.
An encouraging practical sign is the recent report from the
US Council of Foreign Relations and the Milbank Memo-
rial Fund, outlining the importance of health to US for-
eign policy. By acknowledging the relationships between
health, social capital, political stability, the economy and
war a deeper commitment could be developed by the USA
and other nations to the moral and strategic importance
of improving global health [27]. In addition the work of
the Commission on Macroeconomics for Health, [28] the
inauguration of a Global Health Fund, [29] and the recent
announcement by President George Bush that the USA
will increase its annual development aid from $10 billion
to $15 billion [30] reveal both a deeper understanding of
the importance of global health and an acknowledgement
of the responsibility of developed nations to address this
constructively. Further progress will be driven by insights
into how a global awareness and a global community
could be promoted [31].
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